CD4 and ovarian cancer: However, Di et al. detected low expression of CD4+ and CD8+ T cells specific for OCT4 in the blood and ascites of ovarian cancer patients, which may reflect another mechanism by which ovarian tumors evade immune surveillance (Di et al., 2013).